恶性肿瘤的放射治疗联合基因治疗研究进展

田玥; 苏成海

恶性肿瘤的放射治疗联合基因治疗研究进展

田玥 , 苏成海

文章导航 > 国际放射医学核医学杂志 > 2008, 32 > 1: (43-46)

引用本文:

Citation:

恶性肿瘤的放射治疗联合基因治疗研究进展

田玥,
苏成海^,

215006 苏州, 苏州大学附属第一医院核医学科

通讯作者: 苏成海, su323@126.com

中图分类号: R730.5

Advancement of researches on the malignant tumor radio-genetic therapy

TIAN Yue,
SU Cheng-hai^,

Department of Nuclear Medicine, the First Affiliated Hospital of Suzhou University, Suzhou 215006, China

Corresponding author: SU Cheng-hai, su323@126.com

CLC number: R730.5

摘要: 放射治疗是恶性肿瘤治疗的常规手段之一,并早已用于临床。而基因治疗是一种新型的治疗方法,但由于肿瘤的形成是多因素、多基因参与的复杂过程,单纯基因治疗的效果并不理想。因此,放射治疗联合基因治疗是目前的研究热点,也将成为肿瘤治疗研究的重要方向之一。
- 放射疗法 /
- 基因疗法 /
- 肿瘤治疗方案
Abstract: Radiotherapy is one of the routine methods of malignant tumor treatment and used in clinical many years, while gene therapy is one of the new therapy. But the formation of tumor is the complicated process effected by many factors and many genes. The effect of polygene therapy is not ideal. Therefore, radio-genetic therapy is the hot spot of the present study and will become one of the important direction of cancer therapy.
- Radiotherapy /
- Gene therapy /
- Antineoplastic protocols
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Connell PP, Weichselbaum RR. Gene therapy:the challenges of translating laboratory research into clinical practice[J]. J Clin Oncol, 2003, 21(12):2230-2231.
[2]	Weichselbaum RR, Hallahan DE, Beckett MA, et al. Gene therapy targeted by radiation preferentially radiosensitizes tumor cells[J]. Cancer nes, 1994, 54(16):4266-4269.
[3]	Seethram S, Staba MJ, Schumm IP, et al. Enhanced eradication of local and distant tumors by genetically produced interleukin-12 and radiation[J]. Int J Oncol, 1999, 15(4):769-773.
[4]	Gridley DS, Baer JR, Cao JD, et al. TNF-alpha gene and proton radiotherapy in an orthotopic brain tumor model[J]. Int J Oncol, 2002, 21(2):251-259.
[5]	Sherman ML, Datta R, Hallahan DE. Ionizing radiation regulates expression of the c-jun protooncogene[J]. Natl Acad Sci USA, 1990, 87(15):5663-5670.
[6]	Xian J, Yang H, Lin Y, et al. Combination nonviral murine interleukin 2 and interleukin 12 gene therapy and radiotherapy for head and neck squamous cell carcinoma[J]. Arch Otolaryngol Head Neck Surg, 2005, 131(12):1079-1085.
[7]	Haupt S, Haupt Y. Importance of p53 for cancer onset and therapy[J]. Anti Cancer Drugs, 2006, 17(7):725-732.
[8]	Mimeault M, Batra SK. Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies[J]. Carcinogenesis, 2006, 27(1):1-22.
[9]	Baker SJ, Markowitz S, Fearon ER, et al. Suppression of human colorectal carcinoma cell growth by wild-type p53[J]. Science, 1990, 249(4971):912-915.
[10]	Guha A, Mukherjee J. Advances in the biology of astrocytomas[J]. Curr Opin Neurol, 2004, 17(6):655-662.
[11]	张珊文,肖绍文,刘长清,等.头颈鳞癌基因治疗结合放射治疗的临床研究[J].中华肿瘤杂志,2005,27(7):426-428.
[12]	Tan PH, Chan CL, Chan C, et al. The evolving role of gene-based treatment in surgery[J]. Br J Surg, 2005, 92(12):1466-1480.
[13]	Vlachaki MT, Chhikara M, Aguilar L, et al. Enhanced therapeutic effect of multiple injections of HSV-TK+GCV gene therapy in combination with ionizing radiation in a mouse mammary tumor model[J]. Int J Radiat Oncol Biol Phys, 2001, 51(4):1008-1017.
[14]	Chhikara M, Huang H, Vlachaki MT, et al. Enhanced therapeutic effect of HSV-TK+GCV gene therapy and ionizing radiation for prostate cancer[J]. Mol Ther, 2001, 3(4):536-542.
[15]	Rogulski KR, Wing MS, Paielli DL, et al. Double suicide gene therapy augments the antitumor activity of a replication-competent-lytic adenovirus through enhanced cytotoxicity and radiosensitization[J]. Hum Gene Ther, 2000, 11(1):67-76.
[16]	李勇,金宁,杨海山,等.内皮抑素基因联合放射治疗对大鼠Walker-256细胞种植性肿瘤的抑制作用[J].中华放射医学与防护杂志,2005,25(6):531-533.
[17]	隋刚,徐志飞,孙耀昌,等.内皮抑素基因治疗对小鼠肿瘤组织内新生血管形成抑制作用的实验研究[J].中华肿瘤防治杂志,2006,13(12):904-907.
[18]	Ma B, Bristow RG, Kim J, et al. Combined-modality treatment of solid tumors using radiotherapy and molecular targeted agents[J]. J Clin Oncol, 2003, 21(14):2760-2776.
[19]	Wu C, Li Xi, Tian M, et al. Effect of pEgr-TNF[alpha] gene radiotherapy on mice melanoma[J]. Cancer Res, 2005, 15(3):185-190.
[20]	Quentin T, Henke C, Korabiowska M, et al. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression[J]. Anticancer Res, 2004, 24(2):1011-1023.
[21]	Liu LL, Wang JH, Sun BS, et al. Combined IFN-gamma-endostatin gene-therapy and radio-therapy attanuates primary breast tumour growth and lung metastases in a murine model via enhanced CTL and NK cell activation and attenuated tumour angiogenesis:9565[J]. Br J Surg, 2006, 93(S3):11-12.
[22]	杨巍,吴丛梅,李修义,等.pEgr-IFNγ重组质粒辐射诱导表达及其抑瘤作用的实验研究[J].中华放射医学与防护杂志,2003,23(4):238-240.
[23]	Greenberger JS, Bahri S, Jett J, et al. Consideration in optimizing radiation therapy for non-small cell lung cancer[J]. Chest, 1998, 113(1Suppl):46-52.
[24]	Collis SJ, Ketner GW, Hicks JL, et al. Expression of the DNA-PK binding protein E4-34K fails to confer radiation sensitivity to mammalian cells[J]. Int J Radiat Biol, 2003, 79(1):53-60.

[1]	翟红彦 , 苏成海 . 基因治疗联合放射治疗恶性肿瘤的分子机制. 国际放射医学核医学杂志, 2009, 33(2): 113-116. doi: 10.3760/cma.j.issn.1673-4114.2009.02.015
[2]	赵艳芝 , 李进 , 王芹 , 穆传杰 . 恶性肿瘤基因治疗和放射治疗相互作用的机制及联合治疗展望. 国际放射医学核医学杂志, 2006, 30(4): 250-253.
[3]	张耀文 , 曹永珍 , 李进 , 王芹 . 基因治疗联合放射治疗恶性肿瘤. 国际放射医学核医学杂志, 2008, 32(4): 247-250.
[4]	陈冀莹 . 宫颈癌基因治疗联合放射治疗的研究进展. 国际放射医学核医学杂志, 2006, 30(6): 365-368.
[5]	张俊 , 刘增礼 . 钠碘转运体基因介导的肿瘤放射性核素治疗研究. 国际放射医学核医学杂志, 2008, 32(1): 8-11.
[6]	郭睿 , 李彪 . 钠碘同向转运体基因介导放射性碘治疗肿瘤的研究进展. 国际放射医学核医学杂志, 2010, 34(3): 147-151. doi: 10.3760/cma.j.issn.1673-4114.2010.03.005
[7]	段永璇 , 邹晓艳 , 段秀梅 , 李青 . 数据解析在肿瘤放射治疗中的应用. 国际放射医学核医学杂志, 2015, 39(6): 505-508. doi: 10.3760/cma.j.issn.1673-4114.2015.06.015
[8]	王芹 , 刘晓秋 , 李进 , 荣庆林 , 宋力 , 刘强 , 张恒 , 樊飞跃 . 白细胞介素21基因联合不同剂量γ射线照射对乳腺癌细胞生长的影响. 国际放射医学核医学杂志, 2012, 36(2): 94-96. doi: 10.3760/cma.j.issn.1673-4114.2012.02.009
[9]	张春智 , 郭阳 , 吕仲宏 . 辐射敏感性早期生长应答-1基因启动子的研究. 国际放射医学核医学杂志, 2006, 30(2): 120-121,126.
[10]	陈凤华 , 李进 , 谭志军 , 姜恩海 , 宋力 , 王欣茹 , 王芹 . Ad-Rb94联合γ射线照射对食管癌细胞生长的影响. 国际放射医学核医学杂志, 2010, 34(2): 119-121. doi: 10.3760/cma.j.issn.1673-4114.2010.02.017